Inventor · disambiguated record
Brian R. Dixon
Also filed as: DIXON BRIAN R · DIXON BRIAN RICHARD
19 granted patents·6 pending applications·335 citations·filing 1995–2011
96Inventor score
Top patents by PatentIndex Score
25 records- 0194US6500847B2Inhibition of matrix metalloproteases by substitued biaryl oxobutyric acidsBAYER AG·Filed 2001·Granted Dec 31, 2002·31 cites·4 claims
- 0294US5789434ADerivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitorsBAYER AG·Filed 1995·Granted Aug 4, 1998·49 cites·10 claims
- 0388US5886022ASubstituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitorsBAYER AG·Filed 1997·Granted Mar 23, 1999·47 cites·16 claims
- 0486US6784167B217-beta-hydroxysteroid dehydrogenase-II inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 31, 2004·35 cites·17 claims
- 0583US6911449B2Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acidsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Jun 28, 2005·7 cites·4 claims
- 0683US6353006B1Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agentsBAYER AG·Filed 1999·Granted Mar 5, 2002·33 cites·7 claims
- 0783US5968795ABiaryl acetylenes as inhibitors of matrix metalloproteasesBAYER AG·Filed 1997·Granted Oct 19, 1999·33 cites·7 claims
- 0877US5854277AThiophenebutanoic acid derivatives as matrix metalloprotease inhibitorsBAYER AG·Filed 1997·Granted Dec 29, 1998·13 cites·14 claims
- 0973US5859047ASubstituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitorsBAYER AG·Filed 1997·Granted Jan 12, 1999·10 cites·16 claims
- 1072US5863915ASubstituted 4-arylbutyric acid derivatives as matrix metalloproteaseBAYER AG·Filed 1997·Granted Jan 26, 1999·16 cites·13 claims
- 1171US6762184B2Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acidsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Jul 13, 2004·1 cites·4 claims
- 1271US5874473ASubstituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitorsBAYER AG·Filed 1997·Granted Feb 23, 1999·9 cites·16 claims
- 1366US2005267102A1Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acidsBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 1465US5886043ASubstituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitorsBAYER AG·Filed 1997·Granted Mar 23, 1999·5 cites·16 claims
- 1560US6166082ASubstituted 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitorsBAYER AG·Filed 1998·Granted Dec 26, 2000·23 cites·18 claims
- 1659US5861427ASubstituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitorsFiled 1997·Granted Jan 19, 1999·4 cites·16 claims
- 1755US5861428ASubstituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitorsBAYER AG·Filed 1997·Granted Jan 19, 1999·3 cites·16 claims
- 1853US5925637AInhibition of matrix metalloproteases by substituted biaryl oxobutyric acidsBAYER AG·Filed 1997·Granted Jul 20, 1999·8 cites·7 claims
- 1947US5932577ASubstituted oxobutyric acids as matrix metalloprotease inhibitorsBAYER AG·Filed 1997·Granted Aug 3, 1999·3 cites·7 claims
- 2047US2012077781A1Flavin derivativesGADWOOD ROBERT·Filed 2009·Application pending·0 cites
- 2146US6225314B1Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acidsBAYER AG·Filed 1999·Granted May 1, 2001·5 cites·7 claims
- 2241US2003207865A1Substituted 2-arylimino heterocycles and compositions containing them for use as progesterone receptor binding agentsFiled 2001·Application pending·0 cites
- 2335US2013029980A1Flavin derivativesCOISH PHILIP D G·Filed 2011·Application pending·0 cites
- 2433US2012283219A1Diaminopteridine derivativesCOISH PHILIP D G·Filed 2010·Application pending·0 cites
- 2530US2012295903A1Flavin derivativesBLOUNT KENNETH F·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brian R. Dixon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →